Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance

@article{DinisOliveira2017MetabolismOP,
  title={Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance},
  author={Ricardo Jorge Dinis-Oliveira},
  journal={Drug Metabolism Reviews},
  year={2017},
  volume={49},
  pages={84 - 91}
}
Abstract Psilocybin and psilocin are controlled substances in many countries. These are the two main hallucinogenic compounds of the “magic mushrooms” and both act as agonists or partial agonists at 5-hydroxytryptamine (5-HT)2A subtype receptors. During the last few years, psilocybin and psilocin have gained therapeutic relevance but considerable physiological variability between individuals that can influence dose-response and toxicological profile has been reported. This review aims to… Expand
DARK Classics in Chemical Neuroscience: Psilocybin.
TLDR
Preliminary studies with psilocybin have shown promise as potential for the treatment of obsessive compulsive disorder, alcohol addiction, tobacco addiction, and major depressive disorder, and thetreatment of depression in terminally ill cancer patients. Expand
Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms.
TLDR
Two independent monoclonal antibodies against Pyb or Psi are generated, and enzyme-linked immunosorbent assays (ELISAs) developed using the current mAbs are promising tools for identifying illegal hallucinogenic mushrooms. Expand
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Therapeutic deficiencies with monoaminergic antidepressants invites the need to identify and develop novel rapid-acting antidepressants. Hitherto, ketamine and esketamine are identified as safe,Expand
Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis.
TLDR
Monitoring stability of freshly cultivated fruit bodies of Psilocybe cubensis showed that the highest degradation of tryptamines was seen in fresh mushrooms stored at -80°C and the lowest decay wasseen in dried biomass stored in the dark at room temperature. Expand
PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW)
The classical hallucinogens having an affinity towards 5HT2A receptors are discussed, along with their common behavioral effects, toxicity and psychiatric complications which could have long-termExpand
Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective?
Psychedelics extracted by plants have been used in religious, spiritual and mystic practices for millennia. In 1957, Dr. Hofmann have identified and synthesized the prodrug psilocybin, a substanceExpand
Metabolism of lysergic acid diethylamide (LSD): an update
TLDR
Lysergic acid diethylamide is the most potent hallucinogen known and its pharmacological effect results from stimulation of central serotonin receptors (5-HT2) and its metabolism is discussed, by presenting all metabolites as well as clinical and toxicological relevance. Expand
Pharmacokinetic And Pharmacodynamic Aspects Of Peyote And Mescaline: Clinical And Forensic Repercussions.
TLDR
It is clear that most intoxications appear to be mild and are unlikely to produce life-threatening symptoms, which favors the contemporary interest in the therapeutic potential of the drugs of the class. Expand
Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects
TLDR
The aim of this work is to comprehensively review and discuss the toxicokinetics and toxicodynamics of S. divinorum and salvinorin A, highlighting their psychological, physiological, and toxic effects. Expand
Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin.
TLDR
In animal models, psychedelic activity by baeocystin alone was not evident using the mouse head twitch response assay, despite its putative dephosphorylated metabolite, norpsilocin, possessing potent agonist activity at the 5-HT2A receptor. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 75 REFERENCES
Psilocybin – Summary of knowledge and new perspectives
TLDR
This review summarizes all the past and recent knowledge on psilocybin and attempts to describe the mechanism of psychedelic effects and objectify its action using modern imaging and psychometric methods. Expand
Detection of psilocin in body fluids.
TLDR
A GC-MS-method with d(3)-morphine as internal standard and silylation with MSTFA was proved, which proved that psilocin was detected in the urine with REMEDi HS and in serum, most of the p silocin in serum was found in the conjugated form. Expand
The pharmacology of psilocybin
TLDR
All the available pharmacological data about psilocybin are presented and its still growing capacity for abuse and the widely dispersed data are presented. Expand
Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen
The psychotropically active principles of the Mexican hallucinogenic fungus Psilocybe maxicana HEIM have been isolated and obtained in crystalline form. The two new substances, which have been calledExpand
Comparison of psilocin with psilocybin, mescaline and LSD-25
TLDR
Reactions induced by LSD, mescaline, psilocin, and psilocybin are qualitatively similar andPsilocin is approximately 1.4 times as potent as p silocybin, the same as that of the molecular weights of the two drugs. Expand
Comparison of the reactions induced by psilocybin and LSD-25 in man
  • H. Isbell
  • Psychology, Medicine
  • Psychopharmacologia
  • 2004
TLDR
After both drugs, abnormal mental states characterized by feelings of strangeness, difficulty in thinking, anxiety, altered sensory perception (particularly visual), elementary and true visual hallucinations, and alterations of body image were reported by the subjects. Expand
Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.
TLDR
The maximum plasma levels appearing within a very short period indicate a rapid dephosphorylation of PY also when administered systemically, and high performance liquid chromatographic procedures with column-switching coupled with electrochemical detection (HPLC-ECD) for reliable quantitative determination of the PY metabolites psilocin (PI) and 4-hydroxyindole-3-acetic acid (4HIAA) in human plasma were established. Expand
Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man.
TLDR
In humans PI is partially excreted as PI-O-glucuronide and that enzymatic hydrolysis extends the time of detectability for PI in urine samples, which concludes that in humans the limit of quantitation for PI was usually reached 24 h after drug administration. Expand
Psilocybin for treating substance use disorders?
TLDR
A summary of (human) studies on the putative therapeutic effects of psilocybin is provided, and the receptor systems, brain regions and cognitive and emotional processes mediating p silocybin’s effects are discussed. Expand
Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of "magic mushroom".
The concise large-scale syntheses of psilocin (1) and psilocybin (2), the principal hallucinogenic constituents of "magic mushroom", were achieved without chromatographic purification. The key stepExpand
...
1
2
3
4
5
...